Cementos Pacasmayo SAA ADR (CPAC) Stock Forecast & Price Target
Cementos Pacasmayo SAA ADR · NYSE
$12.10+0.07 (+0.58%)
15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 2 firms covering Cementos Pacasmayo SAA ADR, 0 rate it Buy or better, 2 sit at Hold, and 0 rate it Sell or worse, a hold consensus. Targets are tightly clustered, $13.00 to $13.00, so the covering firms are broadly aligned. The average target of $13.00 sits 7% above the current $12.10. The rating mix has held broadly steady over recent months.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS2 ratings
Hold
Strong Buy00%
Buy00%
Hold2100%
Sell00%
Strong Sell00%
Based on 2 analysts giving stock ratings to Cementos Pacasmayo SAA ADR.
As of Jul, 0 of 2 firms rate CPAC a Buy (2 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
CPAC EPS & revenue forecast
EPS · THIS QUARTER
—
Range — – — · 0 analysts
Next period, 0 analysts expect Cementos Pacasmayo SAA ADR to earn — a share (range — – —), versus — a year earlier. Full-year consensus is $0.98, growing to $0.85 the year after.
REVENUE · THIS QUARTER
$0
Range $0 – $0 · 0 analysts
Revenue is expected to reach $0 (range $0 – $0). Full-year consensus is $2.2B, rising to $2.3B next year.
Top analysts covering Cementos Pacasmayo SAA ADR
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on CPAC.
#1
AH
Adrian Huerta
JP Morgan
Hold
$13.00+7.4% to target
Coverage
—
+ Follow
#2
FS
Francisco Suarez Savin
Scotiabank
Hold
$12.80+5.8% to target
Coverage
—
+ Follow
#3
FS
Francisco Suarez
Scotiabank
Hold
$13.00+7.4% to target
Coverage
—
+ Follow
CPAC stock forecast FAQ
What is CPAC's average 12-month price target?+
The 2 analysts with a live target average $13.00 for Cementos Pacasmayo SAA ADR over the next 12 months, ranging from a $13.00 high to a $13.00 low.
Is CPAC stock a Buy, Sell or Hold right now?+
The current consensus is Hold. Of the 2 analyst ratings, 0 are Buy or Strong Buy, 2 are Hold, and 0 are Sell or Strong Sell.
How many Wall Street analysts cover CPAC?+
2 analysts have an active rating on Cementos Pacasmayo SAA ADR, and 2 firms carry a live 12-month price target.
Who is the most accurate analyst covering CPAC?+
Among analysts who currently cover CPAC, Adrian Huerta of JP Morgan has the strongest overall Quantellect track record. Their current call is Hold with a $13.00 target.
What is Cementos Pacasmayo SAA ADR's projected EPS for next quarter?+
The consensus estimate is — per share (range — – —) across 0 analysts. Full-year EPS is projected at $0.98, rising to $0.85 the following year.
How much revenue is Cementos Pacasmayo SAA ADR expected to report next quarter?+
Consensus revenue is $0 (range $0 – $0). Full-year revenue is projected at $2.2B, growing to $2.3B next year.
Have analysts been upgrading or downgrading CPAC lately?+
As of Jul, 0 of 2 firms rate CPAC a Buy (2 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their CPAC calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
